Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q
Komal L. Jhaveri, X.V. Wang, Vicky Makker, Shiuh‐Wen Luoh, Edith Peterson Mitchell, James A. Zwiebel and 14 more
- Rank
- 80 of 4,622
- Percentile
- top 1.8%
- Where
- Annals of Oncology, 2019
- Citations
- 151
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.